secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001193125-26-071516
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight reports Q4 revenue down 19% YoY; 2025 net loss $(38.9M); issues weak 2026 guidance
--------------------------------------------------------------------------------

- Q4 2025 revenue $32.6M (-19% YoY); LAL revenue -1%, LDD revenue -72%.
- FY 2025 revenue $134.5M (-4% YoY); net loss $(38.9M) vs $(27.5M) in 2024.
- LAL unit sales 109,615 (+12% YoY); LDD installed base 1,134 units; procedures >300,000 since launch.
- FY 2026 guidance: revenue $120-135M (down YoY); gross margin 70-72%; op-ex $150-160M.
- Adjusted net loss per share $(0.18) in FY 2025 vs $(0.07) in FY 2024; cash $228.1M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312526071516/0001193125-26-071516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312526071516/rxst-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-071516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer